Selected research
Industry Research
Diammonium Glycyrrhizinate Industry Research Report 2026
Market perspective
The global Diammonium Glycyrrhizinate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Diammonium Glycyrrhizinate market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Diammonium Glycyrrhizinate market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Diammonium Glycyrrhizinate market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Diammonium Glycyrrhizinate include Chia Tai Tianqing Pharmaceutical Group Co. Ltd, Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd, Suzhou Erye Pharmaceutical Co. Ltd, Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd, Jiangsu Tiansheng Pharmaceutical Co. Ltd, Sinopharm Guorui Pharmaceutical Co. Ltd and ND Pharma & Biotech Co. Ltd., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Diammonium Glycyrrhizinate market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Diammonium Glycyrrhizinate.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diammonium Glycyrrhizinate Market by Company
Chia Tai Tianqing Pharmaceutical Group Co. Ltd
Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
Suzhou Erye Pharmaceutical Co. Ltd
Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
Jiangsu Tiansheng Pharmaceutical Co. Ltd
Sinopharm Guorui Pharmaceutical Co. Ltd
ND Pharma & Biotech Co. Ltd.
Diammonium Glycyrrhizinate Segment by Type
Injection
Capsule
Diammonium Glycyrrhizinate Segment by Application
Chronic Viral Hepatitis
Immune Regulation
Diammonium Glycyrrhizinate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diammonium Glycyrrhizinate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diammonium Glycyrrhizinate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diammonium Glycyrrhizinate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Diammonium Glycyrrhizinate companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Capsule
Applications
- Chronic Viral Hepatitis
- Immune Regulation
Companies covered
- Chia Tai Tianqing Pharmaceutical Group Co. Ltd
- Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
- Suzhou Erye Pharmaceutical Co. Ltd
- Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
- Jiangsu Tiansheng Pharmaceutical Co. Ltd
- Sinopharm Guorui Pharmaceutical Co. Ltd
- ND Pharma & Biotech Co. Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Diammonium Glycyrrhizinate by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Injection
- 2.2.3 Capsule
- 2.3 Diammonium Glycyrrhizinate by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Chronic Viral Hepatitis
- 2.3.3 Immune Regulation
- 2.4 Assumptions and Limitations
3 Diammonium Glycyrrhizinate Breakdown Data by Type
- 3.1 Global Diammonium Glycyrrhizinate Historic Market Size by Type (2021-2026)
- 3.2 Global Diammonium Glycyrrhizinate Forecasted Market Size by Type (2027-2032)
4 Diammonium Glycyrrhizinate Breakdown Data by Application
- 4.1 Global Diammonium Glycyrrhizinate Historic Market Size by Application (2021-2026)
- 4.2 Global Diammonium Glycyrrhizinate Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Diammonium Glycyrrhizinate Market Perspective (2021-2032)
- 5.2 Global Diammonium Glycyrrhizinate Growth Trends by Region
- 5.2.1 Global Diammonium Glycyrrhizinate Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Diammonium Glycyrrhizinate Historic Market Size by Region (2021-2026)
- 5.2.3 Diammonium Glycyrrhizinate Forecasted Market Size by Region (2027-2032)
- 5.3 Diammonium Glycyrrhizinate Market Dynamics
- 5.3.1 Diammonium Glycyrrhizinate Industry Trends
- 5.3.2 Diammonium Glycyrrhizinate Market Drivers
- 5.3.3 Diammonium Glycyrrhizinate Market Challenges
- 5.3.4 Diammonium Glycyrrhizinate Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Diammonium Glycyrrhizinate Players by Revenue
- 6.1.1 Global Top Diammonium Glycyrrhizinate Players by Revenue (2021-2026)
- 6.1.2 Global Diammonium Glycyrrhizinate Revenue Market Share by Players (2021-2026)
- 6.2 Global Diammonium Glycyrrhizinate Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Diammonium Glycyrrhizinate Head Office and Area Served
- 6.4 Global Diammonium Glycyrrhizinate Players, Product Type & Application
- 6.5 Global Diammonium Glycyrrhizinate Manufacturers Established Date
- 6.6 Global Diammonium Glycyrrhizinate Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Diammonium Glycyrrhizinate Market Size (2021-2032)
- 7.2 North America Diammonium Glycyrrhizinate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Diammonium Glycyrrhizinate Market Size by Country (2021-2026)
- 7.4 North America Diammonium Glycyrrhizinate Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Diammonium Glycyrrhizinate Market Size (2021-2032)
- 8.2 Europe Diammonium Glycyrrhizinate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Diammonium Glycyrrhizinate Market Size by Country (2021-2026)
- 8.4 Europe Diammonium Glycyrrhizinate Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Diammonium Glycyrrhizinate Market Size (2021-2032)
- 9.2 Asia-Pacific Diammonium Glycyrrhizinate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Diammonium Glycyrrhizinate Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Diammonium Glycyrrhizinate Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Diammonium Glycyrrhizinate Market Size (2021-2032)
- 10.2 South America Diammonium Glycyrrhizinate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Diammonium Glycyrrhizinate Market Size by Country (2021-2026)
- 10.4 South America Diammonium Glycyrrhizinate Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Diammonium Glycyrrhizinate Market Size (2021-2032)
- 11.2 Middle East & Africa Diammonium Glycyrrhizinate Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Diammonium Glycyrrhizinate Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Diammonium Glycyrrhizinate Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd
- 12.1.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Company Information
- 12.1.2 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Business Overview
- 12.1.3 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Revenue in Diammonium Glycyrrhizinate Business (2021-2026)
- 12.1.4 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 12.1.5 Chia Tai Tianqing Pharmaceutical Group Co. Ltd Recent Developments
- 12.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd
- 12.2.1 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Company Information
- 12.2.2 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Business Overview
- 12.2.3 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Revenue in Diammonium Glycyrrhizinate Business (2021-2026)
- 12.2.4 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 12.2.5 Zhejiang Jinhua Kangenbei Bio-Pharmaceutical Co. Ltd Recent Developments
- 12.3 Suzhou Erye Pharmaceutical Co. Ltd
- 12.3.1 Suzhou Erye Pharmaceutical Co. Ltd Company Information
- 12.3.2 Suzhou Erye Pharmaceutical Co. Ltd Business Overview
- 12.3.3 Suzhou Erye Pharmaceutical Co. Ltd Revenue in Diammonium Glycyrrhizinate Business (2021-2026)
- 12.3.4 Suzhou Erye Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 12.3.5 Suzhou Erye Pharmaceutical Co. Ltd Recent Developments
- 12.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd
- 12.4.1 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Company Information
- 12.4.2 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Business Overview
- 12.4.3 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Revenue in Diammonium Glycyrrhizinate Business (2021-2026)
- 12.4.4 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Diammonium Glycyrrhizinate Product Portfolio
- 12.4.5 Shanghai Modern Hasen (Shangqiu) Pharmaceutical Co., Ltd Recent Developments
- 12.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd
- 12.5.1 Jiangsu Tiansheng Pharmaceutical Co. Ltd Company Information
- 12.5.2 Jiangsu Tiansheng Pharmaceutical Co. Ltd Business Overview
- 12.5.3 Jiangsu Tiansheng Pharmaceutical Co. Ltd Revenue in Diammonium Glycyrrhizinate Business (2021-2026)
- 12.5.4 Jiangsu Tiansheng Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 12.5.5 Jiangsu Tiansheng Pharmaceutical Co. Ltd Recent Developments
- 12.6 Sinopharm Guorui Pharmaceutical Co. Ltd
- 12.6.1 Sinopharm Guorui Pharmaceutical Co. Ltd Company Information
- 12.6.2 Sinopharm Guorui Pharmaceutical Co. Ltd Business Overview
- 12.6.3 Sinopharm Guorui Pharmaceutical Co. Ltd Revenue in Diammonium Glycyrrhizinate Business (2021-2026)
- 12.6.4 Sinopharm Guorui Pharmaceutical Co. Ltd Diammonium Glycyrrhizinate Product Portfolio
- 12.6.5 Sinopharm Guorui Pharmaceutical Co. Ltd Recent Developments
- 12.7 ND Pharma & Biotech Co. Ltd.
- 12.7.1 ND Pharma & Biotech Co. Ltd. Company Information
- 12.7.2 ND Pharma & Biotech Co. Ltd. Business Overview
- 12.7.3 ND Pharma & Biotech Co. Ltd. Revenue in Diammonium Glycyrrhizinate Business (2021-2026)
- 12.7.4 ND Pharma & Biotech Co. Ltd. Diammonium Glycyrrhizinate Product Portfolio
- 12.7.5 ND Pharma & Biotech Co. Ltd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst